Neil Almstead
2019
In 2019, Neil Almstead earned a total compensation of $2.5M as Chief Technical Operations Officer at PTC Therapeutics, a 56% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,400 |
|---|---|
| Option Awards | $1,776,569 |
| Salary | $468,000 |
| Other | $16,800 |
| Total | $2,518,769 |
Almstead received $1.8M in option awards, accounting for 71% of the total pay in 2019.
Almstead also received $257.4K in non-equity incentive plan, $468K in salary and $16.8K in other compensation.
Rankings
In 2019, Neil Almstead's compensation ranked 4,826th out of 13,971 executives tracked by ExecPay. In other words, Almstead earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,826 out of 13,971 | 66th |
Division Manufacturing | 1,800 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 626 out of 2,200 | 72nd |
Industry group Drugs | 527 out of 1,886 | 72nd |
Industry Pharmaceutical Preparations | 394 out of 1,398 | 72nd |
Source: SEC filing on April 29, 2021.
Almstead's colleagues
We found four more compensation records of executives who worked with Neil Almstead at PTC Therapeutics in 2019.